News tagged with adverse drug reactions
ER visits tied to ambien on the rise
(HealthDay)—There has been a dramatic increase in the number of emergency-room visits related to sleep medications such as Ambien, according to a new U.S. study.
Medications
May 01, 2013 |
not rated yet |
0
Drugs without side effects: Researchers explore novel ways to classify proteins
Janelle Leuthaeuser is on the cutting edge of biophysics. A molecular genetics and genomics Ph.D. student, she is part of a nationwide effort to create a more efficient generation of protein-based drugs.
Medical research
Apr 26, 2013 |
5 / 5 (1) |
0
|
Lymphoseek approved to help locate lymph nodes
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Cancer
Mar 13, 2013 |
not rated yet |
0
Octaplas approved for blood-clotting disorders
(HealthDay)—Octaplas has been approved by the U.S. Food and Drug Administration to augment insufficient clotting proteins that could otherwise lead to excessive bleeding or excessive clotting.
Medications
Jan 17, 2013 |
not rated yet |
0
Signifor approved for Cushing's disease
(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.
Medications
Dec 17, 2012 |
not rated yet |
0
Recent increase in adverse TMP-SMX reactions in children
(HealthDay)—There has been a significant increase in adverse drug reactions (ADRs) associated with use of trimethoprim-sulfamethoxazole (TMP-SMX) for treatment of skin and soft tissue infection (SSTI) in ...
Pediatrics
Dec 03, 2012 |
not rated yet |
0
Xeljanz approved for rheumatoid arthritis
(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.
Arthritis & Rheumatism
Nov 07, 2012 |
not rated yet |
0
BMJ editor urges Roche to fulfil promise to release Tamiflu trial data
In an open letter to company director, Professor Sir John Bell, she says: "Billions of pounds of public money have been spent on [Tamiflu] and yet the evidence on its effectiveness and safety remains hidden from appropriate ...
Medications
Oct 30, 2012 |
not rated yet |
0
Abraxane approved to treat advanced lung cancer
(HealthDay)—Abraxane (paclitaxel protein-bound) has been approved by the U.S. Food and Drug Administration—in combination with the drug carboplatin—to treat advanced or spreading non-small cell lung ...
Cancer
Oct 14, 2012 |
not rated yet |
0
Calls for more US oversight after tainted drug outbreak
A deadly meningitis outbreak in the United States blamed on a tainted drug has triggered outrage and calls for tighter regulation of the loosely controlled pharmaceutical compounding industry.
Medications
Oct 11, 2012 |
not rated yet |
0
Parent-clinician communication about children's drug reactions needs improvement
Many parents are dissatisfied with communication regarding adverse drug reactions experienced by their child, and the implications of such reactions for the child's future use of medicines, according to a new study published ...
Health
Oct 10, 2012 |
not rated yet |
0
Profs aim to track drug reactions via social media
Experiencing nausea, headaches or other side effects from prescriptions or over-the-counter medicines? Researchers say tweeting about it or posting your concerns online could one day help alert drug companies and federal ...
Medications
Oct 03, 2012 |
not rated yet |
0
Aubagio approved for multiple sclerosis
(HealthDay)—Aubagio (teriflunomide) has been approved by the U.S. Food and Drug Administration to treat adults with relapsing forms of multiple sclerosis (MS).
Medications
Sep 13, 2012 |
not rated yet |
0
Kyprolis approved for multiple myeloma
(HealthDay) -- Kyprolis (carfilzomib) has been approved by the U.S. Food and Drug Administration to treat certain people with multiple myeloma who have already been given at least two prior therapies.
Cancer
Jul 20, 2012 |
not rated yet |
0
Roche probed over faulty drug-safety reporting
Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.
Medications
Jun 21, 2012 |
4 / 5 (1) |
0
